These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11530441)

  • 41. Neuropathological studies of Tourette syndrome.
    Richardson EP
    Adv Neurol; 1982; 35():83-7. PubMed ID: 6959525
    [No Abstract]   [Full Text] [Related]  

  • 42. Tourette syndrome associated with unilateral cystic changes in the gyrus rectus.
    McAbee GN; Wark JE; Manning A
    Pediatr Neurol; 1999 Apr; 20(4):322-4. PubMed ID: 10328286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tourette syndrome.
    Golden GS
    Cleve Clin Q; 1986; 53(2):125-6. PubMed ID: 3461890
    [No Abstract]   [Full Text] [Related]  

  • 44. Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder.
    Durston S; Mulder M; Casey BJ; Ziermans T; van Engeland H
    Biol Psychiatry; 2006 Nov; 60(10):1062-70. PubMed ID: 16712804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonergic and dopaminergic modulation of attentional processes.
    Boulougouris V; Tsaltas E
    Prog Brain Res; 2008; 172():517-42. PubMed ID: 18772049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study.
    Vance A; Silk TJ; Casey M; Rinehart NJ; Bradshaw JL; Bellgrove MA; Cunnington R
    Mol Psychiatry; 2007 Sep; 12(9):826-32, 793. PubMed ID: 17471290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tourette disorder and ADHD.
    Spencer T; Biederman J; Coffey B; Geller D; Faraone S; Wilens T
    Adv Neurol; 2001; 85():57-77. PubMed ID: 11530447
    [No Abstract]   [Full Text] [Related]  

  • 48. Animal models of neuropsychiatric disorders and their relevance for Tourette syndrome.
    Shaywitz BA; Wolf A; Shaywitz SE; Loomis R; Cohen DJ
    Adv Neurol; 1982; 35():199-202. PubMed ID: 6959490
    [No Abstract]   [Full Text] [Related]  

  • 49. Altered cholinergic neurotransmission in Tourette syndrome.
    Ganos C; Hartmann A
    Mov Disord; 2015 Apr; 30(5):638. PubMed ID: 25802004
    [No Abstract]   [Full Text] [Related]  

  • 50. Risky Business: The Circuits that Impact Stress-Induced Decision-Making.
    Arnsten AFT; Lee D; Pittenger C
    Cell; 2017 Nov; 171(5):992-993. PubMed ID: 29149614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Faulty brakes? Inhibitory processes in attention-deficit/hyperactivity disorder.
    Mink JW
    Neurology; 2011 Feb; 76(7):592-3. PubMed ID: 21321332
    [No Abstract]   [Full Text] [Related]  

  • 52. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?
    Mink JW
    Adv Neurol; 2001; 85():113-22. PubMed ID: 11530421
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hyperkinetic syndrome as initial manifestation of AIDS].
    Martínez-Martín P; González Lahoz J; Perea M; Estevez E; Rapún JL
    Neurologia; 1986; 1(3):129-32. PubMed ID: 3274056
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tourette syndrome in children in Norway].
    Surén P; Bakken IJ; Skurtveit S; Handal M; Reichborn-Kjennerud T; Stoltenberg C; Nøstvik LI; Weidle B
    Tidsskr Nor Laegeforen; 2019 Dec; 139(18):. PubMed ID: 31823585
    [No Abstract]   [Full Text] [Related]  

  • 55. Rethinking the nature of inhibitory control deficits in Tourette syndrome.
    Jackson GM; Jackson SR
    Brain; 2020 Mar; 143(3):721-722. PubMed ID: 32203575
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuropathology in Tourette syndrome: an update.
    Swerdlow NR; Young AB
    Adv Neurol; 2001; 85():151-61. PubMed ID: 11530425
    [No Abstract]   [Full Text] [Related]  

  • 57. Changing life styles for children with Tourette syndrome.
    Wang HS
    Biomed J; 2022 Apr; 45(2):227-228. PubMed ID: 35301167
    [No Abstract]   [Full Text] [Related]  

  • 58. Pathogenesis of Tourette syndrome. Clues from the clinical phenotype and natural history.
    Leckman JF; Pauls DL; Peterson BS; Riddle MA; Anderson GM; Cohen DJ
    Adv Neurol; 1992; 58():15-24. PubMed ID: 1414618
    [No Abstract]   [Full Text] [Related]  

  • 59. Neural correlates of attention-deficit/hyperactivity disorder in adulthood.
    Karama S; Evans AC
    Biol Psychiatry; 2013 Oct; 74(8):558-9. PubMed ID: 24075491
    [No Abstract]   [Full Text] [Related]  

  • 60. Tourette syndrome: diagnosis, strategies, therapies, pathogenesis, and future research directions.
    Olson LL; Singer HS; Goodman WK; Maria BL
    J Child Neurol; 2006 Aug; 21(8):630-41. PubMed ID: 16970863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.